Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma

Published:1970-01-01 Issue:1 Volume:47 Page:34-45
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Kim Tae Hyun,Park Joong-Won,Kim Yeon-Joo,Kim Bo Hyun,Woo Sang Myung,Moon Sung Ho,Kim Sang Soo,Koh Young-Hwan,Lee Woo Jin,Park Sang Jae,Kim Joo-Young,Kim Dae Yong,Kim Chang-Min

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://www.e-crt.org/upload/pdf/crt-2013-218.pdf

Reference24 articles.

1. A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular Carcinoma

2. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4 cm

3. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

4. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

5. Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton Beam Radiotherapy as a Curative Alternative to Radiofrequency Ablation for Newly Diagnosed Hepatocellular Carcinoma;Anticancer Research;2024-04-27

2. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-02

3. Tumor Response on Diagnostic Imaging after Proton Beam Therapy for Hepatocellular Carcinoma;Cancers;2024-01-14

4. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-01

5. Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma;Clinical and Molecular Hepatology;2023-10-01